Iron isomaltoside

DRUG11 trials

Conditions

AnemiaAnemia of PregnancyAnemia, Iron DeficiencyAnemia, Iron-DeficiencyAortic Stenosis (Treated With TAVI)Autism Spectrum DisorderChild DevelopmentColorectal Neoplasms

Phase 1

Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

CompletedNCT03013439

Pharmacosmos A/SAnemia, Anemia, Iron Deficiency, Deficiency Diseases +2

Start: 2017-01-06End: 2017-06-04Updated: 2017-12-12

Phase 3

Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia

CompletedNCT03957057

University Medical Centre LjubljanaIron-deficiency, Postpartum Anemia Nos

Start: 2020-09-10End: 2022-06-15Updated: 2022-06-27

Phase 4

Intravenous Iron for Correction of Anaemia After Colorectal Surgery

NCT02999217

Kaunas University of MedicineAnemia, Iron-Deficiency, Colorectal Neoplasms, Colorectal Surgery +1

Start: 2016-10-31End: 2018-10-31Target: 100Updated: 2016-12-21

A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease

CompletedNCT03466983

Pharmacosmos A/SIBD

Start: 2018-05-23End: 2020-05-25Updated: 2021-02-21

Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation

NCT04346004

Yonsei UniversityAortic Stenosis (Treated With TAVI)

Start: 2020-04-27End: 2023-03-31Target: 214Updated: 2020-04-30

Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial

CompletedNCT05358509

Thomas Jefferson UniversityAnemia of Pregnancy, Infant, Low Birth Weight, Iron Deficiency Anemia

Start: 2021-03-15End: 2024-01-21Updated: 2024-05-24

IV Iron-induced Hypophosphatemia After RYGB

RecruitingNCT06350955

Lucie FavreHypophosphatemia, Roux-en-Y Gastric Bypass

Start: 2024-05-02End: 2026-06-30Target: 94Updated: 2024-08-20

Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients

Not yet recruitingNCT06830941

Xie Jingyuan, MDPeritoneal Dialysis (PD), Renal Anemia

Start: 2025-02-15End: 2027-12-31Target: 124Updated: 2025-02-17

Unknown Phase

Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients

TerminatedNCT03610230

The University of Hong KongIron Deficiency Anemia Treatment

Start: 2019-02-01End: 2021-03-30Updated: 2021-10-06

RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study

Active, not recruitingNCT05504863

Thomas Jefferson UniversityAutism Spectrum Disorder, Iron Deficiency Anemia, Neurodevelopmental Abnormality

Start: 2022-10-11End: 2026-01-31Updated: 2023-11-29

Neuroimaging Ancillary Study

CompletedNCT05545527

Thomas Jefferson UniversityChild Development, Fetal Neurodevelopmental Disorder, Iron Deficiency Anemia +3

Start: 2023-02-21End: 2025-04-07Updated: 2025-04-16

Related Papers

Hypophosphatemia attenuates improvements in vitality after intravenous iron treatment in patients with inflammatory bowel disease.

2024-06-141 citations

RAPIDIRON Trial follow-up study - the RAPIDIRON-KIDS Study: protocol of a prospective observational follow-up study.

2023-12-202 citations

DOP89 Effects of ferric derisomaltose and ferric carboxymaltose on hypophosphatemia in iron-deficiency anaemia due to Inflammatory Bowel Disease: A Phase IV randomised clinical trial

Journal of Crohn s and Colitis2021-05-011 citations